Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

Omnicell (OMCL) closed the last trading session at $42.40, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $54.71 indicates a 29% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $11.27. While the lowest estimate of $40 indicates a 5.7% decline from the current price level, the most optimistic analyst expects the ...

Omnicell, Inc. (OMCL) reported fourth-quarter 2024 adjusted earnings per share (EPS) of 60 cents, which surged 81.8% year over year. The metric also beat the Zacks Consensus Estimate by 5.2%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses and RDS restructuring.GAAP EPS was 34 cents compared to a loss of 32 cents in the year-ago period.For the ful ...

Investor Presentation February 6, 2025 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of federal securities laws. These forward-looking statements include statements with respect to 2025 guidance, strategic and growth opportunities, other expectations and other non-historical information. Without limiting the foregoing, statements including the words "expect," "intend," "may," "will," "should," "would," "could," "plan," "potential," "anticipate," "belie ...

Omnicell, Inc. (NASDAQ:OMCL) Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President, Investor Relations Randall Lipps - Founder, Chairman, President and Chief Executive Officer Nchacha Etta - Executive Vice President and Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Jessica Datson - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Scott Schoenhaus - KeyBanc Capital Markets Stan Berenshteyn - Wells Fa ...

Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this Omnicell Inc. Would post earnings of $0.41 per share when it actually produced earnings of $0.56, delivering a surprise of 36.59%.Over the last four quarters, the company ha ...

Exhibit 99.1 "We delivered solid financial results for the fourth quarter of 2024, including returning to year-over-year revenue growth. We are pleased with the improved execution of the business throughout 2024, including strong free cash flows achieved in the year," stated Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. "As we progress through 2025, we remain focused on successfully executing on our strategic priorities, which include driving long-term revenue growth, ...

Omnicell (OMCL) is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s Advanced Services offerings is highly encouraging to sustain growth in the upcoming quarters. Efforts to expand into more overseas markets instill optimism. However, adverse macroeconomic challenges and fierce rival pressure could hurt Omnicell’s performance.Currently sporting a Zacks Rank #1 (Strong Buy), OMCL st ...

The market expects Omnicell (OMCL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...

Omnicell, Inc. (OMCL) has witnessed strong momentum in the past year. Shares of the company have risen 26.2% against 15.7% decline of the industry. The S&P 500 composite has increased 24.2%.With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment.Omnicell develops and markets end-to-end automation solutions for the medication-use process. The company's products enable care providers to improve patient saf ...